Inhibition of Peroxidase and Catalase Activities and Modulation of Hydrogen Peroxide Level by Inositol Phosphoglycan-like Compounds

Abstract

Inositol phosphoglycan-like compounds are produced by the hydrolysis of the membrane bound glycosyl phosphoinositides. Besides being short term mediators of insulin action, they inhibit peroxidases and catalase, increasing the concentration of cellular hydrogen peroxide. Although high concentrations of hydrogen peroxide are toxic, moderate increases of its basal level are signals for different metabolic pathways. The inhibitor, localized in the cytosol of the cell, acts on peroxidases and catalase of the same tissue (homologous action) and of other tissues or organisms (heterologous action). The inositol phosphoglycan-like compound inhibits peroxidases with different prosthetic groups, i.e. containing iron such as: thyroid peroxidase, lactoperoxidase, horseradish peroxidase, soy bean peroxidase; and containing selenium such as glutathione peroxidase and 2-cys peroxiredoxin with no prosthetic group. Besides peroxidases, the inositol phosphoglycan-like compound inhibits catalase, another heme enzyme. The inhibition kinetics demonstrates a noncompetitive effect. The site of action is not the prosthetic group, given that the inhibitor does not produce any effect on the peak in the Soret region in the presence or absence of hydrogen peroxide. In conclusion, the inositol phosphoglycan-like compound is the general inhibitor of peroxidases and catalase involved in the modulation of hydrogen peroxide level that acts in different metabolic pathways as a signal transducer.

oxidoreductases - inhibitor - signal transduction - hydrogen peroxide - metabolic pathways

References

• 1 Saltiel AR. Second messengers of insulin actions.  Diabetes Care. 1990;  13 244-256
• 2 Larner J. Mediators of postreceptor action of insulin.  Am J Med. 1983;  74 38-51
• 3 Jones DR, Varela-Nieto I. The role of glycosyl-phosphatidylinositol in signal transduction.  J Int Biochem Cell Biol. 1998;  30 313-326
• 4 Varela-Nieto I, León Y, Caro HN. Cell signalling by inositol phospho­glycans from different species.  Comp Biochem Physiol. 1996;  115B 223-241
• 5 Fonteles MC, Huang LC, Larner J. Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia.  Diabetologia. 1996;  39 731-734
• 6 Jones DR, Varela-Nieto I. Diabetes and the role of inositol-containing lipids in insulin signaling.  Mol Med. 1999;  5 505-514
• 7 Krawiec L, Pizarro RA, Aphalo P, Cavanagh EMV de, Pisarev MA, Juvenal GJ, Policastro L, Bocanera LV. Role of peroxidase inhibition by insulin in the bovine thyroid cell proliferation mechanism.  Eur J Biochem. 2004;  271 2607-2614
• 8 Lee SF, Huang YT, Wu WS, Lin JK. Induction of c-jun protooncogene expression by hydrogen peroxide through hydroxyl radical generation and p60^src tyrosine kinase activation.  Free Radic Biol Med. 1996;  21 437-448
• 9 Bocanera LB, Aphalo P, Pisarev MA, Gartner R, Silberschmidt D, Juvenal GJ, Beraldi G, Krawiec L. Presence of a soluble inhibitor of thyroid iodination in primary cultures of thyroid cells.  Eur J Endocrinol. 1999;  141 55-60
• 10 DeGroot LJ, Davis AM. Studies on the biosynthesis of iodotyrosine: a soluble thyroidal iodide-peroxidase tyrosine-iodinase system.  Endocrinology. 1962;  70 492-504
• 11 Aebi H. Catalase in vitro.  Meth Enzymol. 1984;  105 121-126
• 12 Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides.  Methods Enzymol. 1994;  233 182-189
• 13 Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues.  J Biol Chem. 1957;  226 497-509
• 14 Caro HN, Kunjara S, Rademacher TW, León Y, Jones DR, Avila MA, Varela-Nieto I. Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver.  Biochem Mol Med. 1997;  61 214-228
• 15 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent.  J Biol Chem. 1951;  193 265-275
• 16 Dunnet CW. A multiple comparison procedure for comparing several treatments with a control.  J Am Statis Assoc. 1955;  50 1096-1121
• 17 Rhee SG, Chae HZ, Kim K. Peroxiredoxins : A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.  Free Rad Biol Med. 2005;  38 1543-1552
• 18 Lineweaver H, Burk D. The determination of enzyme dissociation constants.  J Am Chem Soc. 1934;  56 658-666
• 19 Dixon M, Webb EC. Enzyme inhibition and activation. In: The Enzymes 3rd Ed. New York, Academic Press 1979: 332-467
• 20 Pañeda C, Villar AV, Alonso A, Goñi FM, Varela F, Brodbeck U, León Y, Varela-Nieto I, Jones DR. Purification and characterization of insulin-mimetic inositol phosphoglycan-like molecules from grass pea (Lathyrus sativus) seeds.  Mol Med. 2001;  7 454-460
• 21 Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soy bean.  Biochem Pharmacol. 1997;  54 1087-1096
• 22 Metzler DE. How oxygen meets the electrons with generation of ATP, and other stories. In: Biochemistry. The Chemical Reactions of Living Cells. New York, Academic Press 1977: 559-629

Correspondence